U.S. Markets closed
  • S&P Futures

    4,269.75
    -71.75 (-1.65%)
     
  • Dow Futures

    33,576.00
    -479.00 (-1.41%)
     
  • Nasdaq Futures

    13,880.75
    -277.75 (-1.96%)
     
  • Russell 2000 Futures

    1,930.30
    -42.40 (-2.15%)
     
  • Crude Oil

    86.46
    -0.89 (-1.02%)
     
  • Gold

    1,814.30
    -15.40 (-0.84%)
     
  • Silver

    23.33
    -0.48 (-2.00%)
     
  • EUR/USD

    1.1227
    -0.0018 (-0.1572%)
     
  • 10-Yr Bond

    1.8480
    +0.0650 (+3.65%)
     
  • Vix

    31.96
    +0.80 (+2.57%)
     
  • GBP/USD

    1.3437
    -0.0025 (-0.1881%)
     
  • USD/JPY

    114.6040
    -0.0560 (-0.0488%)
     
  • BTC-USD

    35,959.12
    -1,403.95 (-3.76%)
     
  • CMC Crypto 200

    818.95
    -36.86 (-4.31%)
     
  • FTSE 100

    7,469.78
    +98.32 (+1.33%)
     
  • Nikkei 225

    26,211.03
    -800.27 (-2.96%)
     

28 Stocks Moving In Thursday's Mid-Day Session

  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
·4 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • CEI
  • NURO
  • MRUS

Gainers

  • Camber Energy, Inc.. (NYSE: CEI) jumped 44.2% to $1.3102 after dipping over 40% on Wednesday. Camber Energy filed amended 8K showing financial statements of Viking.

  • Paltalk, Inc. (NASDAQ: PALT) shares jumped 40.1% to $9.71 after dropping over 15% on Wednesday. Paltalk’s recent filing showed registration for $50 million mixed securities shelf offering.

  • Merus N.V. (NASDAQ: MRUS) surged 38.7% to $27.74 as the company presented early clinical data on MCLA-158 and preclinical data on zenocutuzumab at AACR-NCI-EORTC Virtual International Conference on Molecular Targets and Cancer Therapeutics.

  • Cyren Ltd. (NASDAQ: CYRN) jumped 25.1% to $0.6093 after the company announced Nasdaq granted its request for a 180-day extension to regain compliance with Nasdaq's minimum bid price requirement.

  • New Fortress Energy Inc. (NYSE: NFE) shares gained 22.9% to $32.58 after the company issued gas supply and economic guidance.

  • Nutriband Inc. (NASDAQ: NTRB) jumped 15.5% to $7.24. Nutriband's AVERSA Technology recently received Notice of Allowance from USPTO for application titled 'Abuse and Misuse Deterrent Transdermal Systems.'

  • Tata Motors Limited. (NYSE: TTM) surged 14.8% to $25.64 after Morgan Stanley upgraded the company's stock from Equal-Weight to Overweight.

  • Altisource Portfolio Solutions S.A. (NASDAQ: ASPS) rose 14.3% to $11.35 as the company agreed to sell Pointillist subsidiary for $150 million.

  • Aehr Test Systems (NASDAQ: AEHR) gained 13.2% to $15.41 in sympathy with the overall market on optimism Congress will near a deal that would prevent a government shutdown.

  • Biotricity, Inc. (NASDAQ: BTCY) jumped 13.1% to $3.1322. Biotricity announced the launch of Biocare Cardiac application for Samsung's Galaxy Watch4 series.

  • Rocket Lab USA, Inc. (NASDAQ: RKLB) gained 12.9% to $15.80 after the company disclosed that it has been selected to launch NASA's Advanced Composite Solar Sail System.

  • Resources Connection, Inc. (NASDAQ: RGP) jumped 11.3% to $18.61 following upbeat quarterly results.

  • DatChat, Inc. (NASDAQ: DATS) rose 11.1% to $8.18 after dropping 17% on Wednesday.

  • U.S. Silica Holdings, Inc. (NYSE: SLCA) gained 11.2% to $9.44 after the company announced it is commencing a review of strategic alternatives for its Industrial & Specialty Products segment.

  • NeuroMetrix, Inc. (NASDAQ: NURO) rose 9% to $9.40. NeuroMetrix submitted a De Novo request to the FDA for Quell as a prescription treatment for fibromyalgia symptoms in adults. The Company received FDA Breakthrough Designation for this indication in July.

  • AppLovin Corporation (NASDAQ: APP) shares gained 8.8% to $83.74. Twitter agreed to sell its MoPub mobile ad unit to AppLovin for $1.05 billion in cash.

  • Levi Strauss & Co. (NYSE: LEVI) rose 8% to $26.17 as the company posted upbeat Q3 results and raised FY21 earnings forecast.

Check out these big penny stock gainers and losers

Losers

  • Osmotica Pharmaceuticals plc (NASDAQ: OSMT) shares dipped 38.3% to $1.8901 as the company priced its secondary public offering of 14 million shares and warrants to purchase up to 14 million shares at $2.5/piece.

  • Prelude Therapeutics Incorporated (NASDAQ: PRLD) declined 27.6% to $20.85. Prelude Therapeutics announced presentation of data from multiple programs at AACR-NCI-EORTC Virtual International Conference.

  • ORIC Pharmaceuticals, Inc. (NASDAQ: ORIC) dropped 22.1% to $14.82 after the company presented initial clinical data from Phase 1b trial of ORIC-101 in combination with enzalutamide and preclinical data on ORIC-114 at AACR-NCI-EORTC.

  • Cytosorbents Corporation (NASDAQ: CTSO) shares tumbled 15.9% to $6.71.

  • Turning Point Therapeutics, Inc. (NASDAQ: TPTX) dipped 13.5% to $52.51. Turning Point Therapeutics presented updated preliminary clinical data for repotrectinib and elzovantinib at 2021 AACR-NCI-EORTC Conference and issued regulatory updates.

  • Volcon, Inc. (NASDAQ: VLCN) fell 12.5% to $9.50. Volcon shares jumped over 97% on Wednesday as the company priced its IPO at $5.50 per share.

  • ATIF Holdings Limited (NASDAQ: ATIF) dropped 9.6% to $4.22.

  • Xeris Pharmaceuticals, Inc. (NASDAQ: XERS) declined 8.6% to $2.1550.

  • BP Prudhoe Bay Royalty Trust (NYSE: BPT) fell 8.5% to $3.74.

  • NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) shares fell 8.4% to $7.75 after dropping over 4% on Wednesday. NRx Pharmaceuticals recently issued an update on NIH Sponsored ACTIV-3b critical care study.

  • Lamb Weston Holdings, Inc. (NYSE: LW) dropped 6% to $58.61 after reporting Q1 results.

See more from Benzinga

© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.